PGN-EDO51

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study Of PGN-EDO51 In Participants With Duchenne Muscular Dystrophy Amenable To Exon 51-Skipping TreatmentNCT06079736PEPGPhase 2Terminated2025-08-28Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.